Guardant Health raises 2026 revenue outlook to $1.30B-$1.32B as Shield targets 230,000-245,000 tests
Guardant Health, Inc. Common Stock · SERVICES-MEDICAL LABORATORIES · Now $129.14
+2.9% in 3d after detection
Post-detection moves
1h
—
1d
+1.1%
3d
+2.9%
7d
+2.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS